GENERALIDADES.

2021
Syndrome mononucleosique: les ascpects hematologiques.
AMAL HSAIN.
Royaume du Maroc Université Mohammed V Faculté de Médecine et de Pharmacie, Rabat. Idioma: FRANCÉS
 
2020
Características sociodemográficas, clínicas y desenlace de pacientes pediátricos con infección por Virus del Epstein Barr.
MARIA ALEJANDRA MORENO BERMEO.
Universidad del Rosario, Escuela de Medicina y Ciencias de la Salud. Idioma: INGLÉS
 
2018
Yin-Yang 1 Regulation of Epstein-Barr Virus BRLF1 Transcription is Altered During mTORC1 Inhibition in a Cell Type-Specific Manner.
MORAN, STEVEN JAVIER.
he University of North Carolina at Greensboro. Idioma: INGLÉS
 
2013
Immune control of Epstein-Barr virus intection in african children.
SHMANTHI JAYASOORIYA.
The University of Birmingham. Idioma: INGLÉS
 
2009
Epstein-Barr Virus infection in the Edinburgh Student Population.
KAREN F MACSWEEN.
University of Edinburgh. Idioma: INGLÉS
 
2001
Epstein-Barr virus infection in cardiothoracic transplant recipients.
HOPWOOD, PAUL A.
University of Edinburgh Department of Medical Microbiology. Idioma: INGLÉS
 
1976
Systematic Nursing Management of University Students with Infectious Mononucleosis.
LILLIAN N. YELTON.
Loma Linda University. Idioma: INGLÉS
 
1970
Infectious mononuclesois.
CROFTON, R.W.
Edinburgen University. Idioma: INGLÉS
 
1927
Gladular fever: Infectous Mononucleosis or Acüte Benigne Lymphoblatosis: A clinical strudy with soam refereence to etiology.
SCOTT, ANGUS M.
UNiveristy of Glasgow. Idioma: INGLÉS
 
  
FISIOPATOLOGÍA.
 
2023
Epstein – Barr Virus Evasion of Intrinsic and Innate Immune Pathways During the Viral Lytic Cycle.
YIU, STEPHANIE PEI TUNG.
Harvard University Graduate School of Arts and Sciences. Idioma: INGLÉS
 
2021
Syndrome mononucleosique: les ascpects hematologiques.
AMAL HSAIN.
Royaume du Maroc Université Mohammed V Faculté de Médecine et de Pharmacie, Rabat. Idioma: FRANCÉS
 
2019
Metabolic Remodeling of Human B-Cells During Latent Epstein-Barr Virus (EBV) Infectio Latent Epstein-Barr Virus (EBV) Infection.
WANG, LIANG WEJ.
Harvard University. Idioma: INGLÉS
 
2016
Cytotoxic T lymphocyte immunodominance to Epstein-Barr virus infection.
CALUM PHILIP GASCOYNE FORREST.
The University of Birmingham. Idioma: INGLÉS 
 
Mechanisms of immune evasion in Epstein-Barr virus infection.
ANNA M. GRAM.
Leiden University. Idioma: INGLÉS
 
Genetic analysis of the role of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) in B cell transformation.
AGMIESZKA SZYMULA.
Imperial College London Department of Medicine. Idioma: INGLÉS
 
2015
Immunological responses during the incubation period and acute phase of naturally acquired primary Epstein-Barr virus infection.
SAMANTHA K DUNMIRE.
University of MInnesota. Idioma: INGLÉS
 
Hide-and-seek by Epstein-Barr virus: evasion of innate immunity.
MICHIEL VAN GENT.
Universiteit Utrecht. Idioma: INGLÉS  
 
2014
Genetic determinants of EBV infection in Lymphoblastoid Cell Lines.
CZYZ, WITOLD WOJCIECH.
University of Oxford, Saint Cross College. Idioma: INGLÉS
 
2008
The Intracellular Consequences of the Interaction between Epstein Barr Virus Protein BZLF1 and the Human Protein Pax5.
WAKEMAN, BRIAN S.
The University of North Carolina at Greensboro. Idioma: INGLÉS
 
The Role of Regulatory T cells in Primary Infection with Epstein-Barr Virus.
PHOEBE J WINGATE.
The University of Edinburgh. Idioma: INGLÉS
 
Regulation of the Epstein-Barr virus C promoter by the OriP-EBNA1 complex.
CECILIA BORESTRÖM
University of Gothenburg, Institute of Biomedicine. Idioma: INGLÉS
 
Studies on Immune Regulation of Epstein-Barr Virus.
KAREN A. McAULAY.
University of Edinburgh, Laboratory for Clinical and Molecular Virology School of Biomedical Sciences. Idioma: INGLÉS
 
2007
Regulation of the Epstein-Barr Virus Latent Membrane Protein 1 Expression.
PEGA JOHANSSON.
Göteborg University, Institute of Biomedicine Department of Clinical Chemistry and Transfusion Medicine. Idioma: INGLÉS
 
 
2006
Analyse umgelagerter Immunglobulingene in Epstein-Barr Virus infizierten B-Lymphozyten der Infektiösen Mononukleose.
ELISABETH HOCK AUS HANNOVER.
Gedruckt mit Genehmigung der Charité - Universitätsmedizin Berlin Campus Benjamin Franklin. Idioma: ALEMÁN
 
Expression and function of the small immune adaptor protein SAP.
NOÉMI NAGY. 
Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology. Idioma: INGLÉS 
 
2005
An analysis of the immune response to primary Epstein- Barr Virus infection and the association with clinical events.
WILLIAMS, HILARY J.
The University of Edinburgh. Idioma: INGLÉS
 
2004
EBV-Specific CD4+ T Cell Responses in Acute Infectious Mononucleosis: a Dissertation.
MELISSA LYNN PRECOPIO.
University of Massachusetts. Idioma: INGLÉS
 
2003
Transcriptional Regulation of the Epstein-Barr Virus Latent Membrane Protein Gene in B cells.
WEI WEN YANG.
Göteborg University, Institute of Laboratory Medicine Department of Clinical Chemistry and Transfusion Medicine. Idioma: INGLÉS        
 
2002
The role of natural killer T cells in X.linder lynphoproliferative disease.
BRIAN KAI-HO CHUNG.
University of British Columbia. Idioma: INGLÉS   
 
 
 DIAGNÓSTICO
 
2023
Současné možnosti laboratorní diagnostiky EBV.
DENISA JANÚ.
Univerzita Karlota. Idioma: CHECO
 
2013  
Prospective analysis of the primary immune response during naturally acquired EpsteinBarr virus infection in humans
OLUDARE A. ODUMADE.
University of Minnesota. Idioma: INGLÉS 
 
1999
Recombinant Epstein-Barr Virus Proteins and Antibody-selected Peptides: Reagents for Serodiagnosis and Vaccination.
OLIVIA FLYNN.
Dublin City University, School of Biotechnology. Idioma: INGLÉS
 
1996
An electrophoretic analysis of the serum proteins in infectious mononucleosis.
SHANG, JANIE CHING-YIN.
Oregon State University. Idioma: INGLÉS
 
1974
Antibody to Eptein-Barr virus antigens: detection in infectious mononucleosis by radio-iodine lebeling.
MIN-HWA SHEN.
Green State University. Idioma: INGLÉS
 
1945
Some serological aspects of infectious mononuleosis with special reference to the use of agglutinin- absorption test in the diagnosis.
DEMPSTER, JORGE.
University Edimburgen. Idioma: INGLÉS
 
  
TRATAMIENTO.
 
2020
The glycoprotein gp350 of EBV – an in vivo antigen and a promising druggable target molecule.
ELENA FIESTAS CÁRCABA.
Ludwig-Maximilians-Universität München. Idioma: INGLÉS
 
2018
Management of infectious mononucleosis.
PAUL LENNON.
University of Limerick. Idioma: INGLÉS
 
2015
Valganciclovir for the Suppression of Epstein-Barr Virus Replication.
JESSICA EVE YAGER.
University of Washington, Department of Epidemiology. Idioma: INGLÉS
 
2013
Towards A Prophylactic Epstein Barr Virus (EBV) Vaccine To Prevent Ebv-Associated Malignancies And Infectious Mononucleosis And Project 2: Analysing The Transcriptional Response To Histone Deacetylase Inhibitors Treatment In Normal And Cancer Cell Lines.
TEJA BAJT.
College of Life and Environmental Sciences School of Biosciences University of Birmingham. Idioma: INGLÉS
 
 
COMPLICACIONES.
 
2021
Deciphering the Role of Sumoylation During EBV Replication.
JESSICA  L JENKINS.
The University of Tennessee at Knoxville,  School of Medicine.
Idioma: INGLÉS
 
2010
Presencia del virus de Epstein-Barr en la esclerosis múltiple.
SANTIAGO PUERTAS, OLIVIA DEL CARMEN.-
Universidad de Granada. Departamento de Microbiología. Idioma: ESPAÑOL
 
2005
Defining the role of Epstein-Barr virus infection in multiple sclerosis: issues in exposure measurement and misclassification.
SHOUCRI, MARIE-ROSE.
McGill University. Idioma: INGLÉS
 
2004
Elucidación de la vía JNK mediada por la proteína de membrana latente codificada por el virus de Epstein-Barr 1.
WAN JUN.
The Hong Kong University of Science and Technology. Idioma: INGLÉS